Home › Core › ISCC-IDs › 28C8KAbUPjxW3

View ISCC-ID

Core Data

28C8KAbUPjxW3
ISCC-ID - digital asset identifier
CCLTRfgZrq4Nf-CT3MWZCSAyX9d-CDDjsZsT5aXYa-CRZZND6hp9puK
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

tacrolimus for the management of psoriasis clinical utility and place in therapy

Ledger Reference

coblo
Source Ledger/Blockchain
12401327
N-th ISCC Decleration on source ledger
79c0133fa4762fe69760612439197f53c03f900b50867cede1d16c568ee2b2da
Hash of block that includes the ISCC-DECLARATION
627b558e14f535f68a79a9c2d1b7524183a6d981a49c9394795c6f2cbb0b77c5
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Tacrolimus for the management of psoriasis: clinical utility and place in therapy", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Nina Malecic", "@type": "Person"}, {"name": "Helen Young", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5683124?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Informa UK Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.2147/ptt.s101233", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLTRfgZrq4Nf-CT3MWZCSAyX9d-CDDjsZsT5aXYa-CRZZND6hp9puK", "propertyID": "ISCC"}], "datePublished": "2016-12-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close